Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
Pharmaceutical Contract Development & Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Injectable, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing}, End User [Large Pharma, Generic] - Global Forecast to 2029
... Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing, Packaging}, End User [Large Pharma, Generic] - Global Forecast to 2029 The Pharmaceutical Contract Development and Manufacturing Market is ... Read More
-
Global Specialty Injectable Generics Market Size study, by Type (Drugs, Biologics), by Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others) and Regional Forecasts 2022-2028
... approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Specialty Injectable Generics are drug therapies used for the ... Read More
-
Europe Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over the Counter Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Ner
... Respiratory, Hematology, Dermatology, Ophthalmology, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and by Country/Region (Germany, France, U.K., Italy, Spain, Russia, The Netherlands, Poland, Switzerland, Sweden, and Rest of Europe) - ... Read More
-
High Potency APIs Market/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region - Global forecast to 2027
... projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others),
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Antiviral drugs are prescription ... Read More
-
Generic Sterile Injectables Market, by Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Antibiotics, and Others), by Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Disea
... Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 ... Read More
-
Saudi Arabia Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over-the-counter (OTC) Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder
... Hematology, Dermatology, Ophthalmology, and Others (Nutraceutical, Dental and Veterinarian)), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Saudi Arabia pharmaceutical drugs market growth ... Read More
-
Global Generic Drugs Marketto 2027
... Anti-Cancer Drugs, and Others), By Distribution Channel (Pharmacies, Private Clinics, Drug Stores, Hospitals, Retail Pharmacies, and Others), By Region and Forecast till 2027 Global Generic Drugs Market The generic drugs are defined as the medications ... Read More
-
Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Cancer Type (Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, and Others), Route of Administration (Intravenous, Intramuscular, Oral, and Others), Drug Class (HER2 Inhibitor, Immune Checkpoint Inhibitor, PARP Inhibitor, Kinase Inhibitor, and Others), Product (Branded and Generic & Biosimilar), and End User (Hospital, Specialty Clinic, and Others)
... (Intravenous, Intramuscular, Oral, and Others), Drug Class (HER2 Inhibitor, Immune Checkpoint Inhibitor, PARP Inhibitor, Kinase Inhibitor, and Others), Product (Branded and Generic & Biosimilar), and End User (Hospital, Specialty Clinic, and Others) The metastatic cancer ... Read More
-
Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others), and Geography
... Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others), and Geography The generic injectables market is projected to reach US$ 150.65 billion by 2028 from US$ 74.73 billion in 2021; ... Read More
-
Saudi Arabia Pharmaceutical Market; By Drug Type (Branded Drugs and Generic Drugs); By Product Type (Prescription Drugs And OTC (Over-The-Counter) Drugs); By Application (Cardiovascular, Anti-Infective, Musculoskeletal, Oncology, Metabolic Disorder, Central Nervous System, Gastrointestinal, Respiratory, Dermatology, Ophthalmology, Hematology, And Others (Nutraceutical, Dental And Veterinarian)); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, And Online Pharmacy); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Ophthalmology, Hematology, And Others (Nutraceutical, Dental And Veterinarian)); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, And Online Pharmacy); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Saudi Arabia Pharmaceutical Market to Reach USD 19,764 Million ... Read More
-
Generic Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2027, registering a CAGR of 4.27% during the forecast period of 2022-2027. During the early pandemic, COVID-19 has severly impacted the generic drugs market due to the lockdown restrictions and supply chain disruption. Later, there ... Read More
-
High Potency APIs /HPAPI Market- Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)
... 19 pandemic, the High Potency APIs /HPAPI Market was adversely affected. COVID 19 primarily affected the supply chain of the API market. Since Southeast Asia (specifically China and India) is the hub for the production ... Read More
-
Global Meloxicam Market Size study, by Diseases (Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Others) by Drug Type (Generic, Branded) by Population Type (Adult, Children) by Dosage (Oral, Parenteral, transdermal, Others) by Dose Strength (7.5mg, 15mg, Others) by End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others) by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2022-2028
... Others) by End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others) by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2022-2028Global Meloxicam Market is valued approximately USD XX billion in 2021 ... Read More
-
Global Sildenafil Market Size study, by Product Type (Branded and Generics) by Application (Peripheral Vasodilator and Erectile Dysfunction) by End-User (Clinics, Hospitals, and Others) by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2022-2028
... Regional Forecasts 2022-2028Global Sildenafil Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Sildenafil is ... Read More
-
Active Pharmaceutical Ingredient Market: Segmented By Type (Innovative and Generic); By Type of Synthesis (Synthetic and Biotech); By Application (Communicable Diseases, Oncology, Cardiovascular Diseases, Diabetes, Pain Management, Chronic Respiratory Diseases, and Other) and Region – Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030
... Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030 Global Active Pharmaceutical Ingredient to surpass USD 336 billion by 2030 from USD 188 billion in 2020 at a CAGR 6.23% ... Read More
-
Global Generic Injectables Market (2022 Edition) – Analysis By Molecule Type, (Small, Large), Therapeutic Area, Container Type, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2022-2027)
... injectables market was valued at USD 134 billion in the year 2021 with the North American region leading the regional market share. Some of the key factors driving the generic injectables market growth are the ... Read More
-
Global Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Generic Drugs Market ... Read More
-
India Generic Drugs Market; By Product Type (Simple Generics, Super Generics, and Biosimilars); By Route of Administration (Oral, Topical, Injectable, and Others); By Application (Cardiovascular Products, Anti-infective Drugs, Central Nervous System Drugs, Anti-cancer Drugs, Respiratory Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Products, and Others); By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Online Pharmacies); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 India Generic Drugs Market to Grow at 11% during 2022 – 2028 India generic drugs ... Read More
-
Global Generic Drugs Market
... Drugs, and Others), By Distribution Channel (Pharmacies, Private Clinics, Drug Stores, Hospitals, Retail Pharmacies, and Others), By Region and Forecast till 2027 Global Generic Drugs Market The generic drugs are defined as the medications which ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Antiviral drugs are prescription ... Read More
-
Active Pharmaceutical Ingredient (API) Market Size, Share & Trends Analysis By Type, By Manufacturer, By types of Synthesis, By type of Drug, By Therapeutic Application, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
... global active pharmaceutical ingredients market size is projected to reach USD 262.40 billion by 2030. According to SPER Market Research, the global active pharmaceutical ingredients market estimated to reach USD 262.40 Bn by 2030 with ... Read More
-
Gastrointestinal Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change Including: 1) By Type: Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrheals; Others 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others 3) By Route Of Administration: Oral; Parenteral; Others 4) By Drug Classification: Branded Drugs; Generic Drugs 5) By Mode Of Purchase: Prescription-Drugs; Over-The-Counter Drugs Covering: Takeda Pharmaceutical; AbbVie; Johnson & Johnson; Bausch Health; AstraZeneca Plc; Sanofi; Bayer AG; Pfizer Inc.
... gastrointestinal drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 48 geographies. Understand how the ... Read More
-
Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery Including: 1) By Type: Hemophilia; Blood Products; Anemia and Other Blood Disorder Drugs 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others 3) By Route Of Administration: Oral; Parenteral 4) By Drug Classification: Branded Drugs; Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs Covering: Takeda Pharmaceutical Company; Roche Holding AG; Amgen Inc.; Novartis AG; Novo Nordisk A/S; Daiichi Sankyo Company
... hematology drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 48+ geographies. Understand how the ... Read More
-
Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class, By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), By Region, And Segment Forecasts, 2022 - 2030
... is expected to expand at a lucrative CAGR of 5.2% from 2022 to 2030. The key factors driving the market growth include the increasing prevalence of pulmonary arterial hypertension, drug development and technological advancements, product ... Read More
Research Assistance
